In vivo, knockdown or overexpression of G6PD has previously been shown to affect tumor growth in subcutaneous xenograft models in a small number of other cancer systems (17, 28, 52, 53), highlighting the importance of this pathway in cancer cell survival, but not incorporating key components of the tumor microenvironment. The gene discussed is G6PD; the disease is neoplasm.